BCTX
Briacell Therapeutics
BCTX
BCTX
20 hedge funds and large institutions have $17M invested in Briacell Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.02% less ownership
Funds ownership: 0.14% → 0.13% (-0.02%)
49% less capital invested
Capital invested by funds: $33.5M → $17M (-$16.5M)
Holders
20
Holding in Top 10
2
Calls
$7.61M
Puts
$444K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$646K | |
| 3 | +$290K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$159K |
| 5 |
BCM
Bluefin Capital Management
New York
|
+$126K |
Top Sellers
| 1 | -$5.07M | |
| 2 | -$802K | |
| 3 | -$779K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$260K |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$154K |